NHS
NICE yes for Xarelto to treat blood clots
July 25, 2012Sales and Marketing Bayer, DVT, NHS, NICE, Pradaxa, VTE, Xarelto
NICE is recommending Bayer’s Xarelto (rivaroxaban) for the treatment and prevention of deep vein thrombosis (DVT). The watchdog said in …
NICE to assess high cost drugs for rare conditions
July 24, 2012Sales and Marketing AGNSS, NHS, NICE, Rawlins, rare conditions
NICE is to be responsible next year for assessing high cost drugs for people with rare medical conditions as part …
CCGs already improving patient care
July 23, 2012Sales and Marketing CCGs, Commissioning Board, GPs, NHS, NHSCC, reforms
Clinical Commissioning Groups – the new structures set up under the Health and Social Care Act to control most of …
Social care plan criticised
July 13, 2012Sales and Marketing Kings Fund, NHS, king's fund, reform, social care
A leading health think-tank has criticised what it calls the ‘financial vacuum’ at the heart of the government’s plans for …
NHS appoints first CSS managing directors
July 12, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hakin, NHS
The first round of appointments to commissioning support service (CSS) managing director posts has been made by the NHS Commissioning …
Fishburn Hedges hired to review Health Foundation’s profile
July 12, 2012Medical Communications Fishburn Hedges, Health Foundation, NHS
PR firm Fishburn Hedges has been appointed by the Health Foundation to review and refresh the charity’s corporate communications. The …
NHS Board’s draft ‘mandate’ unveiled
July 5, 2012Sales and Marketing CCGs, NHS, NHS Commissioning Board
Health Secretary Andrew Lansley has unveiled the proposed ‘mandate’ for the NHS Commissioning Board, the set of strategic goals the …
Sluggish growth forecast concerns ABPI
July 3, 2012Sales and Marketing ABPI, NHS, OHE, VBP, government
New forecasts suggest that spending on branded drugs may fall in real terms by 2015, leading the ABPI to call …
ABPI to no longer ‘shy away’ from big issues
June 27, 2012Medical Communications, Sales and Marketing ABPI, Callaghan, NHS, VBP, Whitehead
The ABPI will actively seek to tackle tough issues like animal testing and clinical trial problems, as it looks to …
NICE final yes for Zytiga and Tarceva
June 27, 2012Sales and Marketing Janssen, NHS, NICE, NSCLC, Roche, Tarceva, Zytiga
In final guidance published today, NICE is recommending two new drugs for patients with prostate and lung cancer. Janssen’s Zytiga …
London Trust on the brink of going bust
June 26, 2012Sales and Marketing Lansley, NHS, South London Healthcare, reforms
For the first time in its history an NHS Trust is facing bankruptcy and could be dissolved by the government. …
MPs find NHS bodies still blocking treatments
June 25, 2012Sales and Marketing CCGs, MPs, NHS, NICE, PCTs, Pfizer, viagra
The Labour party has uncovered new restrictions to treatments and drugs in the NHS, which it says is hurting patients …
MP criticises drug shortages
June 25, 2012Sales and Marketing ABPI, Labour, NHS, Whitehead, shortages
A Labour MP has attacked major drug shortages in England that are seeing fewer drugs available to patients in the …
NHS makes £700m savings from medicines
June 22, 2012Sales and Marketing Conferederation, NHS, QIPP, reforms
The NHS has made £700 million in savings from prescription medicines over the past year. This is according to the …
Senates and networks – do they have a role in the new NHS?
June 19, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, health forum, reforms, senates and networks
The recent Westminster Health Forum meeting on ‘Developing Clinical Senates and Networks’ focused on one aspect of the new NHS …
Latest content
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
